lobbying_filings_raw: f5c5a149-d448-4017-9bb9-12d5b1a4ebbb

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API. Sortable columns (indexed): filing_type, client_name, filing_year, client_state, registrant_state, registrant_house_id, registrant_id. Sorting on any other column returns HTTP 400 (2026-09-04, #697) — use ?sql= with your own ORDER BY if you need it.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence income_amount expense_amount
f5c5a149-d448-4017-9bb9-12d5b1a4ebbb Q1 12631 FAEGRE DRINKER BIDDLE & REATH LLP 117599 COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS 2019 first_quarter 2019-04-05T10:40:06.667000-04:00 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/f5c5a149-d448-4017-9bb9-12d5b1a4ebbb/", "filing_uuid": "f5c5a149-d448-4017-9bb9-12d5b1a4ebbb", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2019, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/f5c5a149-d448-4017-9bb9-12d5b1a4ebbb/print/", "filing_document_content_type": "text/html", "income": "20000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Ilisa Halpern Paul", "dt_posted": "2019-04-05T10:40:06.667000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": "United States of America", "registrant_address_1": "1500 K Street NW", "registrant_address_2": "Suite 1100", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20005", "registrant": {"id": 12631, "url": "https://lda.senate.gov/api/v1/registrants/12631/", "house_registrant_id": 31801, "name": "FAEGRE DRINKER BIDDLE & REATH LLP", "description": "Law firm", "address_1": "1500 K St NW", "address_2": "Suite 1100", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20005", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "DAVID ZOOK", "contact_telephone": "+1 202-312-7414", "dt_updated": "2026-01-29T11:30:12.415915-05:00"}, "client": {"id": 117599, "url": "https://lda.senate.gov/api/v1/clients/117599/", "client_id": 1005840, "name": "COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS", "general_description": "Increase access to treatment for mental illness, substance abuse and neurological disorder", "client_government_entity": false, "client_self_select": null, "state": "NE", "state_display": "Nebraska", "country": "US", "country_display": "United States of America", "ppb_state": "NE", "ppb_state_display": "Nebraska", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2017-01-06"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Provider status for pharmacists; drug pricing; H.R. The Medicaid Reentry Act; H.R. 838/ S. 265 The Treatment Assesment, Prevention, and Safety Act.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 11526, "prefix": null, "prefix_display": null, "first_name": "JEREMY", "nickname": null, "middle_name": null, "last_name": "SCOTT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 64560, "prefix": null, "prefix_display": null, "first_name": "SARAH", "nickname": null, "middle_name": "T.", "last_name": "MILLS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "FY 2020 Health and Human Services (HHS) appropriations funding for mental health programs.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 64560, "prefix": null, "prefix_display": null, "first_name": "SARAH", "nickname": null, "middle_name": "T.", "last_name": "MILLS", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} DC US 31801 NE NE US US Increase access to treatment for mental illness, substance abuse and neurological disorder 0 0         20000.0  

Links from other tables